Some Background Guidelines On Rapid Systems For Fast Business Loans

Proceeds from the financing will primarily be used by Napo for the commercialization of Mytesi. Mytesi (crofelemer) is the only antidiarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART). Napo introduced Mytesi in the U.S. this past October. Were pleased to have additional funds to build inventory and achieve greater awareness of Mytesi among people living with HIV/AIDS, commented Katie MacFarlane, Senior Vice President of Commercial Development at Napo. Surveys indicate that 1 in 5 people living with HIV ex

... Read more